Literature DB >> 4615631

Characterization of the binding of amphotericin B to Saccharomyces cerevisiae and relationship to the antifungal effects.

J Kotler-Brajtburg, G Medoff, D Schlessinger, G S Kobayashi.   

Abstract

Based on the enhanced fluorescence of amphotericin B in acid solutions, a quantitative assay for this polyene antibiotic has been developed that is sensitive and linear in the range of 0.1 to 10.0 muM. The binding of amphotericin B to Saccharomyces cerevisiae was assayed under various conditions as the amount bound to cells in a dialysis chamber or after centrifugation. Two types of binding were defined: weak, reversible binding occurred at 0 C or higher temperatures and even in the presence of inhibitors of energy metabolism, whereas strong, irreversible binding did not occur at 0 C and was inhibited when energy metabolism was blocked. Only strong binding was correlated with cell killing. Weak binding probably involves the outer layer of the membrane; strong binding probably requires disruption of hydrophobic regions of the cell membrane.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4615631      PMCID: PMC444734          DOI: 10.1128/AAC.6.6.770

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Fluorometric investigations of the interaction of polyene antibiotics with sterols.

Authors:  F Schroeder; J F Holland; L L Bieber
Journal:  Biochemistry       Date:  1972-08-01       Impact factor: 3.162

2.  Temperature effects on the proline transport system of Saccharomyces chevalieri.

Authors:  J Schwencke; N Magaña-Schwencke
Journal:  Biochim Biophys Acta       Date:  1971-08-13

3.  [Extraction of amphotericin-B by extracorporeal hemodialysis].

Authors:  A P Barousse; C De Bercovich; J Firmat; E E Malamud
Journal:  Medicina (B Aires)       Date:  1971 Jan-Feb       Impact factor: 0.653

4.  In vitro susceptibility of isolates of Aspergillus fumigatus and Sporothrix schenckii to amphotericin B.

Authors:  J W Brandsberg; M E French
Journal:  Antimicrob Agents Chemother       Date:  1972-11       Impact factor: 5.191

5.  Amphotericin B therapy in an anephric patient.

Authors:  H A Feldman; J D Hamilton; R A Gutman
Journal:  Antimicrob Agents Chemother       Date:  1973-09       Impact factor: 5.191

6.  Bioassay for hamycin and amphotericin B in serum and other biological fluids.

Authors:  S Shadomy; J A McCay; S I Schwartz
Journal:  Appl Microbiol       Date:  1969-04

7.  Alterations in the permeability of Neurospora crassa due to polyene antibiotics.

Authors:  S C KINSKY
Journal:  J Bacteriol       Date:  1961-12       Impact factor: 3.490

8.  Polyene antibiotic-sterol interactions in membranes of Acholesplasma laidlawii cells and lecithin liposomes. II. Temperature dependence of the polyene antibiotic-sterol complex formation.

Authors:  B de Kruijff; W J Gerritsen; A Oerlemans; P W van Dijck; R A Demel; L L van Deenen
Journal:  Biochim Biophys Acta       Date:  1974-02-26

9.  Polyene antibiotic-sterol interactions in membranes of Acholeplasma laidlawii cells and lecithin liposomes. 3. Molecular structure of the polyene antibiotic-cholesterol complexes.

Authors:  B de Kruijff; R A Demel
Journal:  Biochim Biophys Acta       Date:  1974-02-26

10.  The biogenesis of mitochondria. 3. The lipid composition of aerobically and anaerobically grown Saccharomyces cerevisiae as related to the membrane systems of the cells.

Authors:  D Jollow; G M Kellerman; A W Linnane
Journal:  J Cell Biol       Date:  1968-05       Impact factor: 10.539

View more
  10 in total

1.  Aggregation-dependent changes in susceptibility of Dictyostelium discoideum to amphotericin B.

Authors:  E F Rossomando; M A Hesla; M A Heitz; B Maldonado
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

Review 2.  Carrier effects on biological activity of amphotericin B.

Authors:  J Brajtburg; J Bolard
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

3.  Antimicrobial susceptibility testing of six clinical isolates of Aspergillus.

Authors:  M Kitahara; V K Seth; G Medoff; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

4.  Synthesis-enabled functional group deletions reveal key underpinnings of amphotericin B ion channel and antifungal activities.

Authors:  Daniel S Palacios; Ian Dailey; David M Siebert; Brandon C Wilcock; Martin D Burke
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-28       Impact factor: 11.205

5.  Response of yeast and mycelial phases of Histoplasma capsulatum to amphotericin B and actinomycin D.

Authors:  S C Cheung; G Medoff; D Schlessinger; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1975-10       Impact factor: 5.191

6.  Flow cytometric assay for estimating fungicidal activity of amphotericin B in human serum.

Authors:  E Martin; U Schlasius; S Bhakdi
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

7.  Turbidimetric studies of growth inhibition of yeasts with three drugs: inquiry into inoculum-dependent susceptibility testing, time of onset of drug effect, and implications for current and newer methods.

Authors:  J N Galgiant; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

8.  Increase in colony-forming units of Candida albicans after treatment with polyene antibiotics.

Authors:  J Brajtburg; S Elberg; G Medoff; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

9.  Tissue concentrations and bioactivity of amphotericin B in cancer patients treated with amphotericin B-deoxycholate.

Authors:  N Collette; P van der Auwera; A P Lopez; C Heymans; F Meunier
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

10.  Deleterious effect of serum proteins on the amphotericin B-induced potentiation of cisplatin in human colon cancer cells.

Authors:  M Assem; S Bonvalot; J L Beltramo; C Garrido; M T Dimanche-Boitrel; P Genne; J M Rebibou; D Caillot; B Chauffert
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.